Restrictions on economic activity and supply chain impact caused by COVID-19
First written in FY2020. 4 of 14 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2025-H1.
The whole theme swung hardest in 2020: 102 of 175 companies on the "Worse" side.
- FY2025-H1RestatedAnnual report
「During the current six-month interim consolidated accounting period (1 April 2024–30 September 2024), the truck market, the principal market for our group (the Company and its consolidated subsidiaries), saw demand remain firm in the Japanese market, helped by improvements in parts supply and other factors.」
The disclosure states that demand in the Japanese market remained firm as a result of improved parts supply, reconfirming that the impact of supply chain disruptions had eased. - FY2024MitigatedAnnual report
「During the current fiscal year, the truck market, the principal market for our group, saw semiconductor shortages and other supply chain disruptions subside, while demand remained firm in the Japanese market.」
The disclosure states that semiconductor shortages and other disruptions in the supply chain that had emerged in connection with the spread of COVID-19 had subsided. - FY2024-Q2RestatedAnnual report
「During the first six months of the current fiscal year (1 April 2023–30 September 2023), the truck market, the principal market for our group (the Company and its consolidated subsidiaries), saw semiconductor shortages and other supply chain disruptions subside, while demand remained firm in the Japanese market.」
The disclosure reconfirms that semiconductor shortages and supply chain disruptions had subsided and that demand in the Japanese market remained firm. It does not state that the impacts of the infectious disease and supply chain disruptions had disappeared completely. - FY2024-Q1MitigatedAnnual report
「During the first quarter of the current fiscal year (1 April 2023–30 June 2023), the truck market, the principal market for our group (the Company and its consolidated subsidiaries), saw semiconductor shortages and other supply chain disruptions subside, while unit sales remained firm in the Japanese market.」
The disclosure states that semiconductor shortages and other supply chain disruptions related to the earlier infectious disease and supply chain impacts had subsided, and that sales in the Japanese market remained firm. - FY2023-Q3MitigatedAnnual report
「Against this backdrop, although sales in China were affected by lower production due to the coronavirus and parts shortages, they increased from the same quarter of the previous year as the yen remained weaker against other currencies than in the previous fiscal year. In Japan, sales of products for export remained firm, while sales in Thailand and Indonesia increased from the same quarter of the previous year against a backdrop of economic recovery.」
In China, sales increased year on year despite the continuing impact of lower production due to the coronavirus and parts shortages, partly reflecting the weaker yen. In Japan, Thailand and Indonesia as well, increases in sales and revenue were reported, indicating some improvement from the situation that included lower revenue in China in the previous quarter. - FY2023-Q2Continued impact of the lockdown in China alongside recovery in other regionsAnnual report
「Under these circumstances, the Group's sales in China declined due to lower customer production resulting from the effects of the lockdown and other factors, but increased from the same quarter of the previous year against a backdrop of solid demand in the Japanese market and recovering sales in Thailand and Indonesia.」
While lower customer production and sales due to the lockdown continued in China, demand and sales recovered in Japan, Thailand and Indonesia, with the impact varying by region. - FY2023-Q1WorsenedAnnual report
「Under these circumstances, the Group's sales in Thailand and Indonesia in Asia increased from the same quarter of the previous year against a backdrop of economic recovery. Meanwhile, sales in Japan and China declined from the same quarter of the previous year due to customers' production adjustments resulting from the impact of the lockdown in China.」
The COVID-19-related lockdown in China caused customers to adjust production, which was reflected in lower sales in Japan and China. Meanwhile, sales in Thailand and Indonesia increased against a backdrop of economic recovery. - FY2022-Q3Mitigating impact of the infectious disease and continued impact on parts procurementAnnual report
「Despite the impact on parts procurement from semiconductor shortages and the spread of COVID-19 in Southeast Asia, business remained firm.」
While the report states that the impact of COVID-19 in Southeast Asia has begun to subside, the impact of its spread on parts procurement remains. - FY2022-Q2MaterialisedAnnual report
「Despite the impact on parts procurement from semiconductor shortages and the spread of COVID-19 in Southeast Asia, business remained firm.」
The report states that the spread of COVID-19 was affecting parts procurement in Southeast Asia, with the impact on the supply chain continuing to appear in actual results. - FY2022-Q1MitigatedAnnual report
「During the first quarter of the current consolidated cumulative period (1 April 2021 to 30 June 2021), the global economy continued to show signs of recovery from the effects of COVID-19, which had continued from the previous consolidated fiscal year, although conditions remained uncertain.」
The report states that the recovery from the economic impact of the infectious disease continued, indicating some improvement from the acute phase of economic activity restrictions in the previous year. However, the impact and uncertainty remain. - FY2021-Q3MaterialisedAnnual report
「Under these circumstances, the Group's sales recovered in the third quarter, particularly in China, but declined from the same period of the previous year due to the effects of production cuts and other measures resulting from production adjustments in various countries in response to lower demand during the first half.」
Although sales recovered in the third quarter, particularly in China, the effects of production adjustments and production cuts in the first half remained, resulting in a 16.8% year-on-year decline in cumulative sales. The business impact of the infectious disease continued to appear in the results. - FY2021-Q2MaterialisedAnnual report
「Under these circumstances, the Group's (the Company and its consolidated subsidiaries) sales declined substantially from the same period of the previous year, due to the effects of production adjustments in various countries in response to lower demand, including production stoppages and production cuts.」
Lower demand, production adjustments, production stoppages and production cuts associated with COVID-19 continued to occur, resulting in sales of ¥1,085.2 million, down 26.2% year on year. - FY2021-Q1MaterialisedAnnual report
「Under these circumstances, the Group's (the Company and its consolidated subsidiaries) sales declined substantially from the same quarter of the previous year, due to the effects of production adjustments in various countries in response to lower demand, including production stoppages. As a result, the Group's sales for the cumulative first quarter of the current consolidated fiscal year amounted to ¥510.6 million, down 30.7% year on year.」
Lower demand, production adjustments and production stoppages associated with COVID-19 actually occurred, resulting in a 30.7% year-on-year decline in sales. - FY2020First statedAnnual report
「The Group operates by establishing domestic and overseas supply chains closely coordinated not only with suppliers but also with customers. If economic activity is restricted for public health and safety reasons due to an outbreak of a novel infectious disease or other event, the Group's financial position and operating results may be affected.」
Restrictions on economic activity caused by novel infectious diseases and COVID-19, and their impact on operating results through domestic and overseas supply chains, have been explicitly identified as new risks.